Literature DB >> 2534123

Effect of intraperitoneal injection of mitomycin C adsorbed on activated carbon particles on induction of cytolytic peritoneal macrophages of mice.

M Sakita1, A Iwamoto, K Hata, A Hagiwara, T Takahashi.   

Abstract

The effects of the intraperitoneal injection of mitomycin C adsorbed onto activated carbon particles (MMC-CH) were assessed on the host immune status and the induction of cytolytic peritoneal macrophages (PM) in mice in comparison with an aqueous MMC solution (MMC-AQ). PM from inbred C57BL/6 mice and syngeneic B16 melanoma cells were used as the effector and target cells for the PM-mediated cytotoxicity assay. After a single injection of MMC-AQ (at the dose of 1/2 LD50), the weights of thymus and spleen and the 3H-thymidine uptake of spleen cells stimulated by concanavalin A were markedly decreased compared to those following injection of MMC-CH containing the same dose of MMC. A significant difference was found in the chronological changes of peritoneal exudate cell (PEC) numbers and PM cytolytic activity between the MMC-AQ- and MMC-CH-treated mice. One day after MMC-AQ injection, the PEC numbers were decreased markedly. However, they increased ten-fold after MMC-CH injection and the PM cytolytic activity was significantly higher after MMC-CH injection than after MMC-AQ injection during the first 3 days. The present results suggest the possible superiority of MMC-coated charcoal over free MMC both because of a lessening of the effects on host immunity due to prolonged slow drug release and because of the increase in cytolytic macrophages that was induced.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2534123      PMCID: PMC5917926          DOI: 10.1111/j.1349-7006.1989.tb01662.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  10 in total

1.  [Removal of serum-blocking activities using immobilized protein A columns].

Authors:  M Sakita; S Imaki; K Hata; G Suzuki; T Takahashi; Y Kinemura; K Asakura; T Nomura
Journal:  Nihon Gan Chiryo Gakkai Shi       Date:  1987-08-20

2.  Role of host defense merchanisms in the antitumor activity of adriamycin and daunomycin in mice.

Authors:  A Mantovani; N Polentarutti; W Luini; G Peri; F Spreafico
Journal:  J Natl Cancer Inst       Date:  1979-07       Impact factor: 13.506

3.  In vitro tumor cell killing by peritoneal macrophages from mitomycin C-treated rats.

Authors:  T Ogura; H Shindo; O Shinzato; M Namba; T Masuno; T Inoue; S Kishimoto; Y Yamamura
Journal:  Cancer Immunol Immunother       Date:  1982       Impact factor: 6.968

4.  Adriamycin-activated macrophages as tumor growth inhibitors.

Authors:  J S Haskill
Journal:  Cancer Res       Date:  1981-10       Impact factor: 12.701

5.  Chemotherapy for carcinomatous peritonitis and pleuritis with MMC-CH, mitomycin C adsorbed on activated carbon particles. Clinical trials.

Authors:  A Hagiwara; T Takahashi; R Lee; T Ueda; M Takeda; T Itoh
Journal:  Cancer       Date:  1987-01-15       Impact factor: 6.860

6.  Comparative studies between liposomes containing muramyl dipeptide and various immunomodulators on activation of mouse peritoneal macrophages and NK cells.

Authors:  M Sakita; N Kageyama; S Majima
Journal:  Oncology       Date:  1985       Impact factor: 2.935

7.  Multiple tumoricidal effector mechanisms induced by adriamycin.

Authors:  D Salazar; S A Cohen
Journal:  Cancer Res       Date:  1984-06       Impact factor: 12.701

8.  Tumoricidal effect of macrophages exposed to adriamycin in vivo or in vitro.

Authors:  F Martin; A Caignard; O Olsson; J F Jeannin; A Leclerc
Journal:  Cancer Res       Date:  1982-09       Impact factor: 12.701

9.  Correlation of tumor growth inhibitory activity of macrophages exposed to adriamycin and adriamycin sensitivity of the target tumor cells.

Authors:  R Giavazzi; C D Bucana; I R Hart
Journal:  J Natl Cancer Inst       Date:  1984-08       Impact factor: 13.506

10.  Induction of activated macrophages by intraperitoneal injection of mitomycin C in mice.

Authors:  H Shindo; T Ogura; T Masuno; S Hayashi; S Kishimoto
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.